Vivek A Rudrapatna
Overview
Explore the profile of Vivek A Rudrapatna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rudrapatna V, Cheng Y, Feuille C, Mosenia A, Shih J, Shi Y, et al.
PLoS One
. 2023 Mar;
18(3):e0282267.
PMID: 36862717
Background: Randomized trials are the gold-standard for clinical evidence generation, but they can sometimes be limited by infeasibility and unclear generalizability to real-world practice. External control arm (ECA) studies may...
12.
Arneson D, Elliott M, Mosenia A, Oskotsky B, Solodar S, Vashisht R, et al.
Sci Data
. 2020 Nov;
7(1):405.
PMID: 33199721
Management of the COVID-19 pandemic has proven to be a significant challenge to policy makers. This is in large part due to uneven reporting and the absence of open-access visualization...
13.
Arneson D, Elliott M, Mosenia A, Oskotsky B, Vashisht R, Zack T, et al.
medRxiv
. 2020 Jun;
PMID: 32511606
Management of the COVID-19 pandemic has proven to be a significant challenge to policy makers. This is in large part due to uneven reporting and the absence of open-access visualization...
14.
Rudrapatna V, Glicksberg B, Avila P, Harding-Theobald E, Wang C, Butte A
BMJ Open Qual
. 2020 Mar;
9(1).
PMID: 32209595
Objective: Medical billing data are an attractive source of secondary analysis because of their ease of use and potential to answer population-health questions with statistical power. Although these datasets have...
15.
Ko M, Rudrapatna V, Avila P, Mahadevan U
Dig Dis Sci
. 2020 Feb;
65(10):2979-2985.
PMID: 32034603
Background And Aims: Lower gastrointestinal endoscopy is crucial in the diagnosis and staging of inflammatory bowel disease (IBD). However, there are limited safety data in pregnant populations, resulting in conservative...
16.
Rudrapatna V, Butte A
J Clin Invest
. 2020 Feb;
130(2):565-574.
PMID: 32011317
Real-world data (RWD) continue to emerge as a new source of clinical evidence. Although the best-known use case of RWD has been in drug regulation, RWD are being generated and...
17.
Rudrapatna V, Velayos F
Pract Gastroenterol
. 2019 Aug;
43(4):84-91.
PMID: 31435122
Biosimilars are biologic products that are highly similar to a previously approved reference (or originator) biologic drug in terms of safety, purity, and potency (efficacy). These medications are increasingly being...
18.
Glicksberg B, Oskotsky B, Thangaraj P, Giangreco N, Badgeley M, Johnson K, et al.
Bioinformatics
. 2019 Jun;
35(21):4515-4518.
PMID: 31214700
Motivation: Electronic health records (EHRs) are quickly becoming omnipresent in healthcare, but interoperability issues and technical demands limit their use for biomedical and clinical research. Interactive and flexible software that...
19.
Rudrapatna V, Butte A
Nat Rev Gastroenterol Hepatol
. 2018 Aug;
15(12):715-716.
PMID: 30061595
No abstract available.
20.
Dunn T, Rudrapatna V, Hesse S, Sargsyan Z
Am J Med
. 2017 Mar;
130(8):e341-e342.
PMID: 28344146
No abstract available.